The Haemodialysis and Peritoneal Dialysis Market

Dialysis is a method used to eliminate waste products such as urea and creatinine from blood, which happens from improper functioning of kidneys and is generally needed for people suffering from chronic renal failure. This procedure is carried out for treating kidney disorders and is categorized into 2 types: hemodialysis and peritoneal dialysis. In hemodialysis, blood is removed out of blood vessels and is purified through dialyzer and then pumped back into the body through vascular access. In peritoneal dialysis, the basis procedure remains same; however the inner lining of stomach known as peritoneum is used as a filter to purify blood. The hemodialysis and peritoneal dialysis market growth is ascribed to surge in incidences of kidney associated diseases and problems related to kidney transplants as kidney transplantation includes a major surgery, a donor match, and a lifetime pattern of immunosuppressant drugs to avoid body refutation against the organ. As per the statistics by the National Kidney Foundation, as of 2014, there are more than 2.0 million people across the world are suffering from chronic kidney failure which is currently undergoing dialysis treatment. It is an alternative treatment offered until the patients get a donor and have a successful renal transplantation. Even though the transplant percentages are increasing each year, the dialysis rate is subsequently continuous, due to the identification of new cases of diabetes and renal disorders. In addition to this, the increase in prevalence of lifestyle and chronic diseases such as obesity, diabetes, and hypertension are anticipated to further supplement the global hemodialysis and peritoneal dialysis market growth. Furthermore, the positive initiatives taken by regional governments are also positively influencing hemodialysis and peritoneal dialysis market growth. On the other hand, the risks and complications pertaining to the dialysis will likely to hamper the hemodialysis and peritoneal dialysis market growth.

Furthermore, the developing nations such as China, India, Brazil, and Mexico are projected to create significant growth opportunities for players in the hemodialysis and peritoneal dialysis market. Taiwan and Malaysia have the highest prevalence of treated End-Stage Renal Disease (ESRD) in the 45–65 age groups and the above 75 years age group, as per the US Renal Data System. Additionally, the government funding for the treatment of ESRD, the emergence of home/nocturnal dialysis, and the rising number of dialysis centers are also boosting the growth of hemodialysis and peritoneal dialysis procedures in emerging nations.

The global Haemodialysis and Peritoneal Dialysis Market is segregated on the basis of Type as Hemodialysis and Peritoneal dialysis. Based on Product the global Haemodialysis and Peritoneal Dialysis Market is segmented in Device, Consumables and Services. Based on End-use the global Haemodialysis and Peritoneal Dialysis Market is segmented in Home-based and Hospital-based.

The global Haemodialysis and Peritoneal Dialysis Market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The Haemodialysis and Peritoneal Dialysis Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Analysis

Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Dialife SA and others are among the major players in the global Haemodialysis and Peritoneal Dialysis Market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

• In 2021, Mar Cor (Cantel Medical Corporation) declared the introduction of its innovative EON Portable hemodialysis Water System.
• In 2020, Fresenius Medical Care AG & Co. KGaA declared the launch of a PVC-free peritoneal dialysis solution bag designed for dialysis therapy carried out at home.
• In 2020, Baxter International Inc. gained FDA acceptance for De Novo application for Theranova dilayzers designed to provide expanded hemodialysis (HDx) therapy.
• In 2017, in partnership with The Johns Hopkins Hospital, Fresenius Medical Care AG & Co. KGaA declared plans to inaugurate 8 new dialysis centers. These centers would be situated in Baltimore, U.S., to meet the rising demand within the region.

The global Haemodialysis and Peritoneal Dialysis Market has been segmented as below:

Haemodialysis and Peritoneal Dialysis Market, By Type

• Hemodialysis
• Conventional hemodialysis
• Short daily hemodialysis
• Nocturnal hemodialysis
• Peritoneal dialysis
• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Automated Peritoneal Dialysis (APD)

Haemodialysis and Peritoneal Dialysis Market, By Product

• Device
• Machine
• Dialyzer
• Water treatment system
• Others
• Consumables
• Bloodline
• Concentrates
• Catheters
• Others
• Services

Haemodialysis and Peritoneal Dialysis Market, By End-use

• Home-based
• Hospital-based

Haemodialysis and Peritoneal Dialysis Market, By Region

• Europe
• North America
• Asia Pacific
• Rest of The World

Haemodialysis and Peritoneal Dialysis Market, By Company

• Asahi Kasei Medical Co. Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company
• Dialife SA
• Fresenius Medical Care AG & Co. KGaA
• Kawasumi Laboratories, Incorporation
• MEDTRONIC PUBLIC LIMITED COMPANY
• Nipro Corporation
• Quanta Dialysis Technologies Limited
• Toray Industries Inc.
• WEGO Healthcare Co., Ltd.
• Rockwell Medical, Inc.
• Dialife SA
• Isopure Corp.
• Cantel Medical Corporation
• Nikkiso Co., Ltd.

The report covers the below scope:

• Global Haemodialysis and Peritoneal Dialysis Market sizes from 2020 to 2026, along with CAGR for 2020-2026
• Market size comparison for 2019 vs 2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to 2026
• Global Haemodialysis and Peritoneal Dialysis Market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Haemodialysis and Peritoneal Dialysis Market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

• Base year - 2019
• Estimated year - 2019
• Projected year - 2020
• Forecast period - 2021 to 2026

Report Scope:

The global Haemodialysis and Peritoneal Dialysis Market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Haemodialysis and Peritoneal Dialysis Market share. Major industry players with significant revenue share include Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Dialife SA and others.

Why to Buy this Report:

• Gain detailed insights on the Haemodialysis and Peritoneal Dialysis industry trends
• Find complete analysis on the market status
• Identify the Haemodialysis and Peritoneal Dialysis Market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

• The report targeted towards the existing players in the industry is as follows:
• Market Manufacturers/Service Providers
• Market Wholesale/Traders
• Investment and Financial Institutions

Free and Paid Customization based on the requirement

1.      Introduction

1.1.       Key Points

1.2.      Report Description

1.3.      Markets Covered

1.4.      Stakeholders

2.     Research Methodology

2.1.      Research Scope

2.2.     Research Methodology

2.2.1.     Market Research Process

2.2.2.    Research Methodology

2.2.2.1.           Secondary Research

2.2.2.2.          Primary Research

2.2.2.3.          Models for Estimation

2.3.     Market Size Estimation

2.3.1.     Bottom-Up Approach

2.3.2.    Top-Down Approach

3.     Executive Summary

4.    Market Overview

4.1.      Introduction

4.2.     Drivers

4.3.     Restraints

4.4.     Opportunities

4.5.     Challenges

5.     Haemodialysis and Peritoneal Dialysis Market, By Type

5.1.      Key Points

5.2.     Hemodialysis

5.2.1.      Conventional hemodialysis

5.2.2.     Short daily hemodialysis

5.2.3.     Nocturnal hemodialysis

5.3.     Peritoneal dialysis

5.3.1.      Continuous Ambulatory Peritoneal Dialysis (CAPD)

5.3.2.     Automated Peritoneal Dialysis (APD)

6.    Haemodialysis and Peritoneal Dialysis Market, By Product

6.1.      Key Points

6.2.     Device

6.2.1.     Machine

6.2.2.    Dialyzer

6.2.3.    Water treatment system

6.2.4.    Others

6.3.     Consumables

6.3.1.     Bloodline

6.3.2.    Concentrates

6.3.3.    Catheters

6.3.4.    Others

6.4.     Services

7.     Haemodialysis and Peritoneal Dialysis Market, By End-use

7.1.      Key Points

7.2.  Home-based

7.3.  Hospital-based

8.    Competitive Landscape

8.1.      Introduction

8.2.     Start-up companies- Haemodialysis and Peritoneal Dialysis Market

8.3.     Recent Developments

8.3.1.     Mergers & Acquisitions

8.3.2.    New Product Developments

8.3.3.    Portfolio/Production Capacity Expansions

8.3.4.    Joint Ventures, Collaborations, Partnerships & Agreements

8.3.5.    Others

9.    Company Profile

9.1.  Asahi Kasei Medical Co. Ltd.

9.2. B. Braun Melsungen AG

9.3. Baxter International Inc.

9.4. Becton, Dickinson and Company

9.5.  Dialife SA

9.6. Fresenius Medical Care AG & Co. KGaA

9.7.  Kawasumi Laboratories, Incorporation

9.8. MEDTRONIC PUBLIC LIMITED COMPANY

9.9. Nipro Corporation

9.10.    Quanta Dialysis Technologies Limited

9.11.      Toray Industries Inc.

9.12.    WEGO Healthcare Co., Ltd.

9.13.     Rockwell Medical, Inc.

9.14.    Dialife SA

9.15.     Isopure Corp.

9.16.    Cantel Medical Corporation

9.17.     Nikkiso Co., Ltd.